SG Americas Securities’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64K | Sell |
17,193
-5,681
| -25% | -$21.1K | ﹤0.01% | 2403 |
|
|
2025
Q1 | $74K | Sell |
22,874
-7,010
| -23% | -$22.7K | ﹤0.01% | 2772 |
|
|
2024
Q4 | $166K | Buy |
29,884
+174
| +0.6% | +$967 | ﹤0.01% | 2061 |
|
|
2024
Q3 | $321K | Buy |
+29,710
| New | +$321K | ﹤0.01% | 1846 |
|
|
2024
Q2 | – | Sell |
-4,583
| Closed | -$146K | – | 2555 |
|
|
2024
Q1 | $146K | Sell |
4,583
-22,316
| -83% | -$711K | ﹤0.01% | 1986 |
|
|
2023
Q4 | $545K | Buy |
26,899
+14,645
| +120% | +$297K | 0.01% | 1281 |
|
|
2023
Q3 | $156K | Buy |
+12,254
| New | +$156K | ﹤0.01% | 2245 |
|
|
2023
Q2 | – | Sell |
-6,275
| Closed | -$108K | – | 2226 |
|
|
2023
Q1 | $108K | Sell |
6,275
-2,356
| -27% | -$40.5K | ﹤0.01% | 2607 |
|
|
2022
Q4 | $192K | Sell |
8,631
-12,606
| -59% | -$280K | ﹤0.01% | 2015 |
|
|
2022
Q3 | $171K | Buy |
21,237
+5,928
| +39% | +$47.7K | ﹤0.01% | 2171 |
|
|
2022
Q2 | $107K | Buy |
15,309
+6,967
| +84% | +$48.7K | ﹤0.01% | 2813 |
|
|
2022
Q1 | $126K | Sell |
8,342
-1,338
| -14% | -$20.2K | ﹤0.01% | 2379 |
|
|
2021
Q4 | $212K | Sell |
9,680
-4,517
| -32% | -$98.9K | ﹤0.01% | 2386 |
|
|
2021
Q3 | $383K | Buy |
14,197
+4,932
| +53% | +$133K | ﹤0.01% | 2510 |
|
|
2021
Q2 | $223K | Buy |
+9,265
| New | +$223K | ﹤0.01% | 2065 |
|
|
2021
Q1 | – | Sell |
-33,680
| Closed | -$1.4M | – | 2937 |
|
|
2020
Q4 | $1.4M | Buy |
+33,680
| New | +$1.4M | 0.01% | 1166 |
|